clindamycin

Summary

Summary: An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.

Top Publications

  1. ncbi Antimicrobial susceptibility of coagulase-negative staphylococci isolated from bovine mastitis in Argentina
    E Gentilini
    , Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, Argentina
    J Dairy Sci 85:1913-7. 2002
  2. ncbi Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients
    Caroline A Obert
    Department of Infectious Diseases, St Jude Children s Research Hospital, 332 North Lauderdale St, Memphis, TN 38105 2794, USA
    Antimicrob Agents Chemother 51:386-9. 2007
  3. ncbi [Serotypes and antimicrobial susceptibility of Streptococcus agalactiae]
    María Angélica Martínez
    Programa de Microbiología y Micología, Instituto de Ciencias Biomedicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile
    Rev Med Chil 132:549-55. 2004
  4. ncbi Plasmids of Staphylococcus cohnii isolated from the intensive-care unit
    E M Szewczyk
    Department of Pharmaceutical Microbiology, Medical University of Łódź, 90 235 Łódź, Poland
    Folia Microbiol (Praha) 49:123-31. 2004
  5. ncbi [The phenotype and genotype patterns of erythromycin-resistant Streptococcus pneumoniae]
    Tie-mei Zhao
    Department of Pulmonology, PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 43:329-32. 2004
  6. ncbi Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria
    Sunny Oyakhirome
    Institute for Tropical Medicine, Department for Parasitology, University of Tubingen, Wilhelmstrasse 27, Tubingen, Germany
    Antimicrob Agents Chemother 51:1869-71. 2007
  7. ncbi Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne
    Elizabeth M Seidler
    Clinical Unit for Research Trials in Skin, Massachusetts General Hospital, Boston, Massachusetts 02139, USA
    J Am Acad Dermatol 63:52-62. 2010
  8. ncbi Inducible clindamycin resistance among clinical isolates of Staphylococci
    A M Ciraj
    Department of Microbiology, Melaka Manipal Medical College, Manipal University, Manipal, Karnataka 576 104, India
    Indian J Pathol Microbiol 52:49-51. 2009
  9. ncbi Clindamycin as an antimalarial drug: review of clinical trials
    Bertrand Lell
    Medical Research Unit, Albert Schweitzer Hospital, , Gabon
    Antimicrob Agents Chemother 46:2315-20. 2002
  10. ncbi Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study
    Per Goran Larsson
    Department of Obstetrics and Gynaecology, Karnsjukhuset, SE 541 85 Skövde, Sweden
    BMC Womens Health 8:3. 2008

Detail Information

Publications217 found, 100 shown here

  1. ncbi Antimicrobial susceptibility of coagulase-negative staphylococci isolated from bovine mastitis in Argentina
    E Gentilini
    , Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, Argentina
    J Dairy Sci 85:1913-7. 2002
    ..40, 0.38, 4.00, 0.75, 0.75, 3.60, and 2.00 for penicillin, oxacillin, cephalothin, gentamicin, erythromycin, clindamycin, and ampicillin-sulbactam, respectively. Resistance was detected in 34 (27.6%), 4 (3.2%), 7 (5.7%), and 6 (4...
  2. ncbi Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients
    Caroline A Obert
    Department of Infectious Diseases, St Jude Children s Research Hospital, 332 North Lauderdale St, Memphis, TN 38105 2794, USA
    Antimicrob Agents Chemother 51:386-9. 2007
    ..One-third of the isolates harbored a known resistance mechanism. Q-D is not optimal for use for the treatment of pneumococcal infection in SCD patients...
  3. ncbi [Serotypes and antimicrobial susceptibility of Streptococcus agalactiae]
    María Angélica Martínez
    Programa de Microbiología y Micología, Instituto de Ciencias Biomedicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile
    Rev Med Chil 132:549-55. 2004
    ..In the last decade, a dramatic increase in the resistance of this microorganism to erythromycin and clindamycin has been observed.
  4. ncbi Plasmids of Staphylococcus cohnii isolated from the intensive-care unit
    E M Szewczyk
    Department of Pharmaceutical Microbiology, Medical University of Łódź, 90 235 Łódź, Poland
    Folia Microbiol (Praha) 49:123-31. 2004
    ..were grouped in antibiotic-resistance clusters established for 9 antibiotics (gentamicin, ciprofloxacin, clindamycin, erythromycin, tetracycline, chloramphenicol, mupirocin, trimethoprim-sulfamethoxazole, vancomycin) using the ..
  5. ncbi [The phenotype and genotype patterns of erythromycin-resistant Streptococcus pneumoniae]
    Tie-mei Zhao
    Department of Pulmonology, PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 43:329-32. 2004
    ..pneumoniae. METHODS: The minimum inhibitory concentration (MIC) of erythromycin, clindamycin, penicillin and fluoroquinolones against 192 strains of S...
  6. ncbi Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria
    Sunny Oyakhirome
    Institute for Tropical Medicine, Department for Parasitology, University of Tubingen, Wilhelmstrasse 27, Tubingen, Germany
    Antimicrob Agents Chemother 51:1869-71. 2007
    Fosmidomycin-clindamycin therapy given every 12 h for 3 days was compared with a standard single oral dose of sulfadoxine-pyrimethamine...
  7. ncbi Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne
    Elizabeth M Seidler
    Clinical Unit for Research Trials in Skin, Massachusetts General Hospital, Boston, Massachusetts 02139, USA
    J Am Acad Dermatol 63:52-62. 2010
    Comparative efficacy of the multiple treatments containing benzoyl peroxide (BPO) and clindamycin (CL) is not established.
  8. ncbi Inducible clindamycin resistance among clinical isolates of Staphylococci
    A M Ciraj
    Department of Microbiology, Melaka Manipal Medical College, Manipal University, Manipal, Karnataka 576 104, India
    Indian J Pathol Microbiol 52:49-51. 2009
    Clinical failure of clindamycin therapy has been reported due to multiple mechanisms that confer resistance to macrolide, lincosamide and streptogramin antibiotics...
  9. ncbi Clindamycin as an antimalarial drug: review of clinical trials
    Bertrand Lell
    Medical Research Unit, Albert Schweitzer Hospital, , Gabon
    Antimicrob Agents Chemother 46:2315-20. 2002
  10. ncbi Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study
    Per Goran Larsson
    Department of Obstetrics and Gynaecology, Karnsjukhuset, SE 541 85 Skövde, Sweden
    BMC Womens Health 8:3. 2008
    ..was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen ..
  11. ncbi Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris
    J J Leyden
    Department of Dermatology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA
    Am J Clin Dermatol 2:33-9. 2001
    BACKGROUND: Topical clindamycin and benzoyl peroxide have each demonstrated clinical efficacy in the treatment of acne vulgaris...
  12. ncbi Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora
    Ronald F Lamont
    Department of Obstetrics and Gynaecology, Northwick Park and St Mark s Hospital, Watford Road, Harrow, Middlesex, London HA1 3UJ, United Kingdom
    Obstet Gynecol 101:516-22. 2003
    To assess the ability of clindamycin vaginal cream to reduce the incidence of preterm birth in women with abnormal genital tract flora in the second trimester of pregnancy.
  13. ncbi Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples
    V Deotale
    Department of Microbiology, Mahatma Gandhi Institute of Medical Sciences, Sevagram Dist Wardha, M S 442 102, India
    Indian J Med Microbiol 28:124-6. 2010
    b>Clindamycin is commonly used in the treatment of erythromycin resistant Staphylococcus aureus causing skin and soft tissue infections...
  14. ncbi Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital
    Paul C Schreckenberger
    University of Illinois Medical Center at Chicago, Rm 238 CSB, M C 750, 840 S Wood St, Chicago, IL 60612, USA
    J Clin Microbiol 42:2777-9. 2004
    The incidences of inducible clindamycin resistance at two hospitals (an inner-city hospital and a suburban community hospital) were 7 and 12% for methicillin-resistant Staphylococcus aureus, 20 and 19% for methicillin-susceptible S...
  15. ncbi In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin
    Jochen Wiesner
    Institute of Biochemistry, Academic Hospital Centre, Justus Liebig University, Giessen, Germany
    Antimicrob Agents Chemother 46:2889-94. 2002
    ..Synergy was observed between fosmidomycin and the lincosamides, lincomycin and clindamycin. The efficacy of a combination of fosmidomycin and clindamycin was subsequently demonstrated in the Plasmodium ..
  16. ncbi Detection and prevalence of inducible clindamycin resistance in staphylococci
    Gurdal Yilmaz
    Department of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University School of Medicine, 61080 Trabzon, Turkey
    J Med Microbiol 56:342-5. 2007
    ..The resistance to antimicrobial agents among staphylococci is an increasing problem. Clindamycin (CL) is considered to be one of the alternative agents in these infections...
  17. ncbi Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study
    John E Wolf
    Baylor College of Medicine, Dermatology Department, Houston, TX 77030, USA
    J Am Acad Dermatol 49:S211-7. 2003
    ..1% plus clindamycin phosphate lotion 1%, compared with clindamycin plus vehicle for the treatment of mild to moderate acne vulgaris...
  18. ncbi The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product
    J J Leyden
    University of Pennsylvania Health System, Philadelphia, USA
    J Cutan Med Surg 5:37-42. 2001
    BACKGROUND: Topical clindamycin and benzoyl peroxide have each demonstrated clinical efficacy in the treatment of acne vulgaris...
  19. ncbi Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clindamycin phosphate
    Nitin Dobaria
    Pharmacy Department, Centre of Relevance and Excellence in Novel Drug Delivery Systems, G H Patel building, The M S University of Baroda, Vadodara, India
    Pharm Dev Technol 15:405-14. 2010
    To develop more effective treatment for bacterial vaginosis, bioadhesive film formulations of clindamycin phosphate (CL) for vaginal delivery were studied. The bioadhesive films were prepared by solvent evaporation method...
  20. ncbi Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes
    Masaaki Minami
    Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho cho, Mizuho ku, Nagoya 467 8601, Japan
    Antimicrob Agents Chemother 54:98-102. 2010
    The administration of high-dose clindamycin (CLI) along with penicillin is recommended for the treatment of streptococcal toxic shock syndrome...
  21. ncbi Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis
    J Sobel
    Division of Infectious Diseases, Detroit Medical Center, Wayne State University School of Medicine, MI 48201, USA
    Infect Dis Obstet Gynecol 9:9-15. 2001
    OBJECTIVE: To compare the efficacy and safety of a 3-day regimen of clindamycin vaginal ovules with a 7-day regimen of clindamycin vaginal cream for the treatment of bacterial vaginosis (BV)...
  22. ncbi Lincomycin, clindamycin and their applications
    J Spizek
    Institute of Microbiology, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague, Czech Republic
    Appl Microbiol Biotechnol 64:455-64. 2004
    Lincomycin and clindamycin are lincosamide antibiotics used in clinical practice. Both antibiotics are bacteriostatic and inhibit protein synthesis in sensitive bacteria...
  23. ncbi Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial
    Michael Ramharter
    Albert Schweitzer Hospital, , Gabon, Germany
    Clin Infect Dis 40:1777-84. 2005
    ..open-label, randomized, controlled clinical trial to evaluate the efficacy and tolerability of oral artesunate-clindamycin therapy given twice daily for 3 days (artesunate, 2 mg/kg, and clindamycin, 7 mg/kg, per dose), compared with a ..
  24. ncbi Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: results from a 52-week open-label study
    Leon H Kircik
    Indiana University School of Medicine, Indianapolis, USA
    Cutis 82:358-66. 2008
    ..The combination treatment is a gel formulation containing a crystalline suspension of clindamycin phosphate 1.2%-tretinoin 0.025% (CLIN/RA)...
  25. ncbi Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris
    Joel Schlessinger
    Advanced Skin Research Center, Omaha, NE, USA
    J Drugs Dermatol 6:607-15. 2007
    b>Clindamycin phosphate 1.2% and tretinoin 0.025% gel (CLIN/RA gel [ZIANA Gel]) is a novel topical combination agent approved by the FDA for the treatment of acne vulgaris in patients 12 years of age or older...
  26. ncbi Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris
    M Badawy Abdel-Naser
    Dessau Medical Center, Departments of Dermatology, Venereology, Allergology and Immunology, Auenweg 38, 06847 Dessau, Germany
    Expert Opin Pharmacother 9:2931-7. 2008
    b>Clindamycin phosphate 1.2% together with tretinoin 0.025% as a gel (CTG) is a topical formulation of a fixed and stable combination approved by the FDA for the treatment of acne vulgaris in patients 12 years of age or older...
  27. ncbi A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris
    William J Cunliffe
    Department of Dermatology, The General Infirmary, Leeds, United Kingdom
    Clin Ther 24:1117-33. 2002
    ..OBJECTIVE: The purpose of this study was to compare the antimicrobial and clinical efficacy and tolerability of clindamycin phosphate 1%/benzoyl peroxide 5% gel formulation with matching clindamycin 1% gel in the treatment of acne ..
  28. ncbi Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations
    Guy Webster
    Jefferson Dermatology Service, Wilmington Department of Veterans Affairs Medical Center, Wilmington, PA, USA
    J Drugs Dermatol 8:736-43. 2009
    ..Oral antibiotics are commonly prescribed for moderate or severe acne, but there may be limitations due to concerns about side effects associated with systemic treatments...
  29. ncbi A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years
    Lawrence F Eichenfield
    Rady Children s Hospital and University of California, San Diego, San Diego, California 92123, USA
    Pediatr Dermatol 26:257-61. 2009
    ..Recently, the US FDA approved the combination of 1.2% clindamycin (CLIN) and 0...
  30. ncbi Inducible clindamycin resistance in Staphylococcus aureus: a study from North India
    V Gupta
    Department of Microbiology, Government Medical College Hospital, Chandigarh, India
    J Postgrad Med 55:176-9. 2009
    ..The resistance to macrolide can be mediated by msr A gene coding for efflux mechanism or via erm gene encoding for enzymes that confer inducible or constitutive resistance to macrolide, lincosamide and Type B streptogramin...
  31. ncbi Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole
    M N Austin
    Magee Womens Research Institute, Pittsburgh, PA 15213 3180, USA
    J Clin Microbiol 43:4492-7. 2005
    ..women aged 18 to 45 with clinical and Gram stain evidence of BV were randomized to receive intravaginal clindamycin or metronidazole...
  32. ncbi Transdermal absorption of clindamycin and tretinoin from topically applied anti-acne formulations in man
    E J van Hoogdalem
    Clinical Pharmacology Research Department, Yamanouchi Europe B V, Leiderdorp, The Netherlands
    Biopharm Drug Dispos 19:563-9. 1998
    The percutaneous absorption of clindamycin was studied in healthy male volunteers, comparing two investigative clindamycin (% w/v)/tretinoin (0...
  33. ncbi A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris
    E H Tschen
    Academic Dermatology Associates, Albuquerque, New Mexico, USA
    Cutis 67:165-9. 2001
    A topical gel combining 5% benzoyl peroxide and 1% clindamycin as phosphate was evaluated in a 10-week randomized double-blind trial involving 287 patients with moderate to moderately severe acne...
  34. ncbi Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile
    Michael Gerber
    Institute of Medical Microbiology and Epidemiology of Infectious Diseases, University of Leipzig, Liebigstrasse 24, 04103 Leipzig, Germany
    J Med Microbiol 57:776-83. 2008
    ..difficile-associated diarrhoea (CDAD). The impact of metronidazole (MTR), vancomycin (VAN), clindamycin (CLI) and linezolid (LZD) on growth, toxin gene transcription and toxin production in C...
  35. ncbi Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites
    Neekesh V Dharia
    Department of Cell Biology, ICND 202, The Scripps Research Institute, La Jolla, California 92037, USA
    Genome Res 20:1534-44. 2010
    ..isolates we discovered point mutations in the apicoplast genome that are close to known mutations that confer clindamycin resistance in other species, but which were hitherto unknown in malaria parasites...
  36. ncbi Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008
    Joshua C Herigon
    Children s Mercy Hospital and Clinics, Section of Infectious Diseases, 2401 Gillham Rd, Kansas City, MO 64108, USA
    Pediatrics 125:e1294-300. 2010
    ..The objective of this study was to describe trends in antibiotic management for Staphylococcus aureus infections among hospitalized children from 1999 to 2008...
  37. ncbi Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer
    Paolo Bidoli
    Medical Oncology Unit, S Gerardo Hospital, Monza, Italy
    J Thorac Oncol 5:1662-3. 2010
    ..No effective treatment for the rash is available...
  38. ncbi Prevalence of inducible clindamycin resistance in staphylococcal isolates at a Korean tertiary care hospital
    Hwan Sub Lim
    Department of Laboratory Medicine, Kwandong University College of Medicine, Kyunggi, Korea
    Yonsei Med J 47:480-4. 2006
    b>Clindamycin resistance in Staphylococcus species can be either constitutive or inducible. Inducible resistance cannot be detected by the conventional antimicrobial susceptibility test...
  39. ncbi Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes
    Jun Sawai
    Department of Molecular Bacteriology, Nagoya University Graduate School of Medicine, Japan
    Antimicrob Agents Chemother 51:461-7. 2007
    The administration of high-dose clindamycin plus benzylpenicillin has been recommended for the treatment of streptococcal toxic shock-like syndrome caused by Streptococcus pyogenes, and clindamycin has been found to be more effective ..
  40. ncbi Inducible clindamycin resistance in staphylococci isolated from clinical samples
    Nuran Delialioglu
    Department of Microbiology and Clinical Microbiology, Mersin University Faculty of Medicine, Mersin, Turkey
    Jpn J Infect Dis 58:104-6. 2005
    ..The double-disc test was applied by placing erythromycin and clindamycin discs on these isolates to investigate the inducible and constitutive MLS(B) resistance phenotypes and MS ..
  41. ncbi No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections
    Jillian M Szczesiul
    Department of Pharmacy, The Johns Hopkins Hospital, The Johns Hopkins University, Baltimore, MD, USA
    Pediatr Infect Dis J 26:852-4. 2007
    ..our institution revealed 98% of methicillin-resistant Staphylococcus aureus (MRSA) isolates were susceptible to clindamycin; however, beta-lactams were then the predominant empiric treatment...
  42. ncbi Solid state NMR and bioequivalence comparison of the pharmacokinetic parameters of two formulations of clindamycin
    Z A Al-Talla
    Analytical Core Lab, King Abdullah University of Science and Technology, KAUST, Thuwal, Kingdom of Saudi Arabia
    Int J Clin Pharmacol Ther 49:469-76. 2011
    ..was to compare the pharmacokinetic parameters and determine the bioequivalence of a generic formulation of clindamycin that is sold in the local markets in the Middle East (Clindox® 150 mg capsule; test) with a reference ..
  43. ncbi A novel gel formulation of clindamycin phosphate-tretinoin is not associated with acne flaring
    James J Leyden
    KGL, Inc, Broomall, Pennsylvania 19008, USA
    Cutis 82:151-6. 2008
    ..In 3 multicenter, double-blind, randomized, phase 3 trials of a clindamycin phosphate 1.2%-tretinoin 0...
  44. ncbi Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris
    James J Leyden
    Department of Dermatology, University of Pennsylvania Hospital, Philadelphia, Pennsylvania, USA
    J Am Acad Dermatol 54:73-81. 2006
    The development of a hydrogel to stabilize and solubilize clindamycin and tretinoin provides a single, once-daily treatment for acne vulgaris.
  45. ncbi Prevalence of inducible clindamycin resistance in gram positive organisms in a tertiary care centre
    M R Angel
    Department of Clinical Microbiology, Christian Medical College and Hospital, Vellore 632 004, India
    Indian J Med Microbiol 26:262-4. 2008
    ..For these infections, clindamycin is a useful alternate drug in penicillin-allergic patients...
  46. ncbi Topical clindamycin in the management of acne vulgaris
    David R P Guay
    University of Minnesota, College of Pharmacy, Department of Experimental and Clinical Pharmacology, Weaver Densford Hall 7 148, 308 Harvard Street SE, Minneapolis, MN, 55455, USA
    Expert Opin Pharmacother 8:2625-64. 2007
    ..These include oral tetracycline, doxycycline, minocycline and topical clindamycin and erythromycin...
  47. ncbi Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus
    Soma T Govender
    Department of Neurosurgery, Wentworth Hospital, Nelson R. Mandela School of Medicine, University of Natal, Durban, South Africa
    J Neurosurg 99:831-9. 2003
    ..The AIS system represents another important tool to enable the neurosurgeon to prevent shunt infections...
  48. ncbi In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum
    M Ramharter
    Department of Parasitology, Institute for Tropical Medicine, University of Tuebingen, Germany. ramhartergmx.at
    Antimicrob Agents Chemother 47:3494-9. 2003
    ..This study was conducted to evaluate the antimalarial potential of clindamycin in combination with dihydroartemisinin in continuously cultured and in freshly isolated Plasmodium falciparum ..
  49. ncbi An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients
    Diane Thiboutot
    Department of Dermatology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
    J Am Acad Dermatol 59:792-800. 2008
    We sought to evaluate efficacy, safety, and tolerability of a combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% (clindamycin-BPO 2.5%) aqueous gel in moderate to severe acne vulgaris.
  50. ncbi Influence of clindamycin on the stability of coa and fnbB transcripts and adherence properties of Staphylococcus aureus Newman
    Maren Blickwede
    , , , 31535 Neustadt-Mariensee, Germany
    FEMS Microbiol Lett 252:73-8. 2005
    We investigated whether a subinhibitory concentration of clindamycin (Cli), corresponding to 1/2 the strain-specific minimum inhibitory concentration (MIC), could affect expression and stability of transcripts from genes coding for ..
  51. ncbi An alternative high-performance liquid chromatographic method for determination of clindamycin in plasma
    K Na-Bangchang
    Pharmacology and Toxicology Unit, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand
    Southeast Asian J Trop Med Public Health 37:177-84. 2006
    ..and reproducible method based on a reversed-phase chromatography was developed for the determination of clindamycin in human plasma...
  52. ncbi Acute generalized exanthematous pustulosis due to clindamycin
    Ronald J Sulewski
    Resurrection Hospital, Chicago, IL, USA
    Dermatol Online J 14:14. 2008
    ..Three cases of clindamycin induced AGEP have been reported in the literature...
  53. ncbi Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Cutis 81:405-8. 2008
    An aqueous gel formulation containing solubilized clindamycin phosphate 1.2% and a stable combination of both solubilized and crystalline tretinoin 0...
  54. ncbi Phenotypic detection of inducible clindamycin resistance among Staphylococcus aureus isolates by using the lower limit of recommended inter-disk distance
    G S Ajantha
    Department of Microbiology, SDM College of Medical Sciences and Hospital, Sattur, Dharwad 580 009, Karnataka, India
    Indian J Pathol Microbiol 51:376-8. 2008
    b>Clindamycin is one of the important alternative antibiotics in the therapy of Staphylococcus aureus, particularly in methicillin-resistant S. aureus (MRSA) infections...
  55. ncbi Treatment of community-associated methicillin-resistant Staphylococcus aureus infections
    Sheldon L Kaplan
    Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA
    Pediatr Infect Dis J 24:457-8. 2005
  56. ncbi Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne
    Emil Tanghetti
    Center for Dermatology and Laser Surgery, Sacramento, CA 95819, USA
    J Drugs Dermatol 7:534-8. 2008
    ..Benzoyl peroxide (BPO) is poorly soluble. A solubilized formulation of BPO has been developed to maximize its bioavailability and enhance follicular penetration...
  57. ncbi Enterococcal surface protein Esp does not facilitate intestinal colonization or translocation of Enterococcus faecalis in clindamycin-treated mice
    Nicole J Pultz
    Infectious Diseases Section (111W, Louis Stokes Cleveland Veterans Affairs Medical Center, Case Western Reserve University, 10701 East Blvd, Cleveland, OH 44106, USA
    FEMS Microbiol Lett 242:217-9. 2005
    ..faecalis to mesenteric lymph nodes. After clindamycin treatment, similar levels of high-density colonization were established after orogastric inoculation of an E...
  58. ncbi Differences in the Enterococcus faecalis lsa locus that influence susceptibility to quinupristin-dalfopristin and clindamycin
    Kavindra V Singh
    Center for the Study of Emerging and Reemerging Pathogens, University of Texas Medical School Houston, 6431 Fannin, Houston, TX 77030, USA
    Antimicrob Agents Chemother 49:32-9. 2005
    ..lsa gene, encoding the putative ABC protein Lsa, influences resistance to quinupristin-dalfopristin (Q-D) and clindamycin (CLI). We have now found that, while cloned lsa from E...
  59. ncbi Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results
    M Desjardins
    Division of Microbiology, Department of Medicine, The Ottawa Hospital, 501 Smyth Rd, Ottawa, ON, Canada
    J Clin Microbiol 42:5620-3. 2004
    ..Cross-resistance to clindamycin may be present, depending on the mechanism of resistance...
  60. ncbi Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen
    P G Larsson
    Department of Obstetrics and Gynaecology, Karnsjukhuset, Skovde, Sweden
    BJOG 113:629-37. 2006
    To screen for bacterial vaginosis (BV) and to investigate the effect of treatment with vaginal clindamycin in order to observe the effect on late miscarriage and delivery prior to 37 completed weeks (primary outcome).
  61. ncbi Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals
    S Johnson
    Department of Medicine, Veterans Affairs Chicago Health Care System, Lakeside Division, and Northwestern University Medical School, IL 60611, USA
    N Engl J Med 341:1645-51. 1999
    ..Since frequent use of clindamycin was associated with the outbreak in one of the hospitals, we examined the resistance genes of the epidemic-..
  62. ncbi Clindamycin phosphate scavenges hydroxyl radical
    Emiko Sato
    New Industry Creation Hatchery Center, Tohoku University, Sendai, Japan
    Int J Dermatol 46:1185-7. 2007
    b>Clindamycin phosphate (CLDMP) is effective against Gram-positive and anaerobic bacteria, and is known to have anti-inflammatory properties.
  63. ncbi Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci
    E M Mascini
    Eijkman Winkler Institute for Microbiology, Infectious Diseases, and Inflammation, University Medical Center, G04 614, P O Box 85500, NL 3508 GA, Utrecht, The Netherlands
    Int J Antimicrob Agents 18:395-8. 2001
    ..Current antibiotics used for the treatment of these infections are penicillin and clindamycin. The effects of sub- and suprainhibitory concentrations of penicillin and clindamycin were evaluated in 14 ..
  64. ncbi Efficacy of antibiotic-impregnated shunt catheters in reducing shunt infection: data from the United Kingdom Shunt Registry
    Hugh K Richards
    United Kingdom Shunt Registry, Addenbrooke s Hospital, Cambridge, United Kingdom
    J Neurosurg Pediatr 4:389-93. 2009
    In recent years CSF shunt catheters impregnated with rifampicin and clindamycin have been introduced to the United Kingdom (UK) market...
  65. ncbi High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan
    P R Hsueh
    Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
    Antimicrob Agents Chemother 45:3205-8. 2001
    ..Of the erythromycin-resistant isolates, 86.3% had the macrolide-lincosamide-streptogramin (MLS) resistance phenotype (constitutive MLS, 85.5%; inducible MLS, 0.8%) and 13.7% had the M phenotype...
  66. ncbi Neutropenia after single-dose clindamycin for dental prophylaxis
    Joseph S Bubalo
    Department of Pharmacy Services, Oregon Health Sciences University, USA
    Pharmacotherapy 23:101-3. 2003
    A 68-year-old man with stable chronic myelogenous leukemia received a single dose of clindamycin before having a tooth extracted. He was neutropenic 6 days later, with an absolute neutrophil count of 945 cells/mm3...
  67. ncbi Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp
    L B Duffy
    University of Alabama at Birmingham, 35294, USA
    J Antimicrob Chemother 45:29-33. 2000
    ..drugs were levofloxacin, trovafloxacin, grepafloxacin, azithromycin, clarithromycin, tetracycline and clindamycin. MICs were determined using a microbroth dilution method...
  68. ncbi Decrease of erythromycin resistance in group A streptococci by change of emm distribution
    Eun Ha Koh
    Department of Laboratory Medicine, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Korea
    Jpn J Infect Dis 61:261-3. 2008
    ..In the present study, resistance rates to erythromycin and clindamycin in 2004 decreased to 9.8 and 8.8%, respectively, compared with 51.0 and 33.7%, respectively, in 2002...
  69. ncbi Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients
    Francisco Carlos Groppo
    Department of Physiological Sciences, Dentistry School of Piracicaba, UNICAMP, Brazil
    Gen Dent 53:410-3. 2005
    ..0% to azithromycin, 27.6% to clarithromycin, 23.3% to erythromycin, 3.3% to cefazolin, and 6.7% to clindamycin. Regarding streptococci, 16.7% of the strains were resistant to ampicillin, 16.7% to amoxicillin, 23...
  70. ncbi Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae
    Esther Culebras
    Servicio de Microbiologia, Hospital Clinico San Carlos, Plaza Cristo Rey s n, Madrid, 28040, Spain
    J Antimicrob Chemother 56:836-40. 2005
    ..To study the regulatory region of a constitutively expressed erm(A) gene in Streptococcus agalactiae clinical isolates...
  71. ncbi Activities of clindamycin, synercid, telithromycin, linezolid, and mupirocin against Gram-positive coccal strains resistant to erythromycin in Korea
    Ae Ran Kwon
    College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151742, Korea
    Arch Pharm Res 30:840-3. 2007
    The antibacterial activities of clindamycin, synercid, telithromycin, linezolid and mupirocin were evaluated against erythromycin-resistant Gram-positive coccal clinical isolates collected in Korean hospitals...
  72. ncbi Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae
    C Betriu
    Department of Clinical Microbiology, Hospital Clinico San Carlos, 28040 Madrid, Spain
    Antimicrob Agents Chemother 47:1112-4. 2003
    The rates of resistance to erythromycin and clindamycin among Streptococcus agalactiae strains isolated in our hospital increased from 4.2 and 0.8% in 1993 to 17.4 and 12.1%, respectively, in 2001...
  73. ncbi Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey
    O K Azap
    Baskent University Faculty of Medicine, Infectious Disease and Clinical Microbiology, Ankara, Turkey
    Clin Microbiol Infect 11:582-4. 2005
    In total, 408 staphylococcal isolates were tested for inducible clindamycin resistance (ICR) by the disk-diffusion induction test (D-test). ICR was detected in 5.7% of 105 methicillin-resistant Staphylococcus aureus (MRSA) isolates, 3...
  74. ncbi Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany
    T E Schoening
    Hygiene-Institut, , Heidelberg, Germany
    Clin Microbiol Infect 11:579-82. 2005
    ..The overall frequencies of erythromycin and clindamycin resistance were 11% and 4.7%, respectively...
  75. ncbi An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus
    Forest W Arnold
    University of Louisville School of Medicine, KY 40292, USA
    J Ky Med Assoc 103:206-10. 2005
    ..Reviewing risk factors in adult patients with CA-MRSA in Kentucky has not been reported...
  76. ncbi Anti-microbial susceptibility of Streptococcus spp. isolated from bovine mastitis in Argentina
    G Denamiel
    , Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, Chorroain 280 (1427) Buenos Aires, Argentina
    J Vet Med B Infect Dis Vet Public Health 52:125-8. 2005
    The in vitro susceptibility to penicillin G, erythromycin and clindamycin was determined by the disc diffusion test and by E-test for a total of 47 streptococcal strains (three Streptococcus uberis, 36 Streptococcus agalactiae, eight ..
  77. ncbi Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline
    Jutta Wagner
    Department of Medical Microbiology and Immunology of Infection, Institute of Infectious Diseases Medicine, Benjamin Franklin Medical Center, Free University of Berlin, 12203 Berlin
    Antimicrob Agents Chemother 47:2358-61. 2003
    ..Campylobacter jejuni resistance to antibiotics in Germany, MICs of ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline were determined (using agar dilution) for 144 clinical isolates...
  78. ncbi Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey
    B Sener
    Hacettepe University Medical Faculty, Dept of Microbiology and Clinical Microbiology, 06100 Ankara, Turkey
    J Chemother 17:31-5. 2005
    ..The minimum inhibitory concentrations (MICs) of penicillin G, erythromycin A and clindamycin were determined by the agar dilution method according to NCCLS guidelines. Ninety-one (13...
  79. ncbi Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California
    Hsin Huang
    Department of Infectious Disease, University of California, Davis, Medical Center, 4150 V Street, PSSB, G500, Sacramento, CA 95817, USA
    J Clin Microbiol 44:2423-7. 2006
    ..Ninety-six percent of the CA-MRSA isolates were susceptible to clindamycin. Double-disk diffusion tests were performed to examine inducible clindamycin resistance by erythromycin ..
  80. ncbi In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes
    G Novotna
    Institute of Microbiology, Academy of Sciences of the Czech Republic, 142 20 Prague, Czechia
    Folia Microbiol (Praha) 52:593-9. 2007
    ..epidermidis and S. warnerii indicating its widespread occurrence in CoNS. Misidentification of low-level resistant isolates by DDM may contribute to dissemination of streptogramin A resistance...
  81. ncbi [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci]
    Esma Gunduz Kaya
    XII Türk Klinik Mikrobiyoloji ve infeksiyon Hastaliklan Kongresi nde
    Mikrobiyol Bul 40:161-8. 2006
    ..also determined resistance phenotypes of resistant strains by double disc synergy method using erythromycin and clindamycin discs. Twelve of 282 strains (4.3%) were found resistant to erythromycin; five (41...
  82. ncbi Inhibitory activity of garlic (Allium sativum) extract on multidrug-resistant Streptococcus mutans
    M M Fani
    Department of Oral Medicine, School of Dentistry, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
    J Indian Soc Pedod Prev Dent 25:164-8. 2007
    ..Considering in vitro data obtained in the present study, mouthwashes or toothpaste containing optimum concentration of garlic extract could be used for prevention of dental caries...
  83. ncbi [Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections]
    R Cohen
    Groupe de pathologie infectieuse pédiatrique de la Société française de pédiatrie, Hopital Armand Trousseau, 26 av Docteur Arnold Netter 75012 Paris, France
    Arch Pediatr 14:S122-7. 2007
    ..aureus strains are methicillin susceptible and dosages of cephalosporins are increased. Clindamycin is a very interesting alternative, if the strains are susceptible to macrolides.
  84. ncbi Agar dilution method for detection of inducible clindamycin resistance in Staphylococcus spp
    Clarence J Fernandes
    Department of Microbiology, Royal North Shore Hospital, Sydney, New South Wales, Australia
    J Clin Microbiol 45:4018-20. 2007
    We describe the development and validation of an agar dilution method for the detection of inducible clindamycin resistance by using 227 previously characterized erythromycin-resistant, clindamycin-susceptible Staphylococcus sp. isolates...
  85. ncbi Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells
    Jana M Swenson
    Antimicrobial Resistance Team, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Microbiol 45:3954-7. 2007
    A study conducted by 11 laboratories investigated the ability of four combinations of erythromycin (ERY) and clindamycin (CC) (ERY and CC at 4 and 0.5, 6 and 1, 8 and 1.5, and 0...
  86. ncbi Rapid determination of macrolide and lincosamide resistance in group B streptococcus isolated from vaginal-rectal swabs
    Wilfred P dela Cruz
    Clinical Investigation Facility, David Grant USAF Medical Center, Travis Air Force Base, CA 94535, USA
    Infect Dis Obstet Gynecol 2007:46581. 2007
    ..Our objective was to assess the ability of real-time PCR to predict in vitro resistance in isolates of group B streptococcus (GBS)...
  87. ncbi Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002
    Ying Yan Chen
    Research and Diagnostics Center, Centers for Disease Control, Taipei, Taiwan
    Diagn Microbiol Infect Dis 58:289-95. 2007
    ..9%). Antimicrobial resistance profiles were determined, and resistance to erythromycin (24.6%), clindamycin (2.0%), and chloramphenicol (1.3%) was detected...
  88. ncbi Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic
    Stefanie Heller
    Microbiological Research, Basilea Pharmaceutica AG, Grenzacherstrasse 487, Postfach, CH 4005 Basel, Switzerland
    Antimicrob Agents Chemother 51:1956-61. 2007
    ..MICs indicated that BAL19403 was very active against erythromycin-resistant and clindamycin-resistant propionibacteria with mutations in the region from positions 2057 to 2059 (Escherichia coli numbering)..
  89. ncbi Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains
    Robyn L Woodbury
    Division of Bacterial Diseases, Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Antimicrob Agents Chemother 52:1140-3. 2008
    ..from population-based invasive GAS surveillance in the United States were erythromycin resistant, inducibly clindamycin resistant, and lacked known macrolide resistance determinants...
  90. ncbi Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia
    Ralf R Reinert
    Institute for Medical Microbiology, National Reference Center for Streptococci, University Hospital RWTH, Aachen, Germany
    Antimicrob Agents Chemother 52:2260-2. 2008
    ..7%], or both erm(B) and mef(E) (30.3%). Isolates with dual resistance genes [erm(B) and mef(E)] belonged to clonal complex CC81 or CC271...
  91. ncbi Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey
    Cagri Ergin
    J Dermatol 33:899-901. 2006
  92. ncbi Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vi
    Kerry L LaPlante
    Anti Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan 48201, USA
    Antimicrob Agents Chemother 52:2156-62. 2008
    ..Staphylococcus aureus (CA-MRSA) and about the ability of these strains to develop inducible resistance to clindamycin during therapy...
  93. ncbi Susceptibility of Streptococcus thermophilus to antibiotics
    Lorenzo Tosi
    Institute of Microbiology, Universita Cattolica del Sacro Cuore, Via Emilia Parmense 84, 29100, Piacenza, Italy
    Antonie Van Leeuwenhoek 92:21-8. 2007
    ..isolates collected between 1948 and 2005 from different environments were investigated to assess erythromycin, clindamycin, streptomycin, gentamicin, tetracycline and ampicillin susceptibility by means of microdilution, Etest and disk ..
  94. ncbi Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications
    Edward L Kaplan
    Department of Microbial Pathogenesis and Vaccine Research, GBF German Research Centre for Biotechnology, Braunschweig, Germany
    Clin Infect Dis 43:1398-406. 2006
    ..We examined the viability of ingested, intracellular GAS after epithelial cell exposure to antibiotics commonly recommended for therapy of GAS infections...
  95. ncbi Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain
    L Merino Díaz
    Servicio de Microbiologia, Hospitales Universitarios, Virgen del Rocio, Sevilla, Spain
    Clin Microbiol Infect 14:85-7. 2008
    Susceptibility to erythromycin and clindamycin was determined in 860 consecutive clinical isolates of beta-haemolytic streptococci belonging to groups A (GAS, n = 134), B (GBS, n = 689), C (GCS, n = 19) and G (GGS, n = 18)...
  96. ncbi Antimicrobial-resistance and enterotoxin-encoding genes among staphylococci isolated from expressed human breast milk
    Leticia A M Carneiro
    Disciplina de Microbiologia e Imunologia, Faculdade de Ciencias Medicas, Universidade do Estado do Rio de Janeiro, Avenida 28 de Setembro, 87, Fundos 3o andar, 20551 030, Rio de Janeiro, Brazil
    J Med Microbiol 53:761-8. 2004
    ..3 %). All strains were susceptible to clindamycin and vancomycin...
  97. ncbi Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates
    J Figueira-Coelho
    Laboratory of Microbiology, Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Portugal
    Microb Drug Resist 10:31-6. 2004
    ..Resistance was found to tetracycline (75.4%), erythromycin (10.7%), and clindamycin (9.9%). Of the 27 erythromycin-resistant isolates, 70.4% had the cMLS(B), 22.2% the iMLS(B), and 7...
  98. ncbi Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile
    Elizabeth L Palavecino
    Laboratory Services, Universidad Catolica, Santiago, Chile
    Int J Antimicrob Agents 20:108-12. 2002
    ..Our results showed that 22 (56.5%) were macrolide-resistant, clindamycin-susceptible isolates (M phenotype) and 17 (43.5%) were macrolide and clindamycin resistant (MLS(B) phenotype)...
  99. ncbi Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model
    Myo-Kyoung Kim
    Department of Pharmacy Research, Division of Infectious Diseases, Office for Research, Hartford Hospital, Connecticut 06102, USA
    Antimicrob Agents Chemother 46:3185-92. 2002
    ..These data reveal that an approximate cethromycin AUC(free)/MIC of 50 or C(max free)/MIC of 1 results in bacteriostatic effects, while higher values (twofold) maximize survival...
  100. ncbi Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing
    J H Jorgensen
    Department of Pathology, University of Texas Health Science Center, San Antonio, Texas 78229, USA
    J Clin Microbiol 42:1800-2. 2004
    This study has shown that inducible clindamycin resistance in staphylococci can be detected by disk testing on sheep blood agar inoculum purity plates used with the bioMerieux VITEK 2...
  101. ncbi Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area
    Meredith E Hasenbein
    Department of Laboratory Medicine, Children's Hospital Boston and Harvard Medical School, Massachusetts 02115, USA
    J Clin Microbiol 42:1559-63. 2004
    Macrolide (including erythromycin and azithromycin) and lincosamide (including clindamycin) antibiotics are recommended for treatment of penicillin-allergic patients with Streptococcus pyogenes pharyngitis...

Research Grants91

  1. International Congress on Microsporidiosis
    Louis Weiss; Fiscal Year: 2004
    ..Overall, the goal of this congress is to foster the exchange of information between these diverse groups of scientists leading to advances in research on these emergent pathogens. ..
  2. Molecular Epidemiology, Virulence, and Genomic Characterization of Ureaplasmas
    Ken Waites; Fiscal Year: 2007
    ....
  3. Candida-endothelial interactions under conditions of flow
    Martin Thornhill; Fiscal Year: 2007
    ....
  4. Second International Workshop on Microsporidia from Vertebrate and Invertebrate H
    Louis Weiss; Fiscal Year: 2007
    ..Overall, the goal of this congress is to foster the exchange of information between these diverse groups of scientists leading to advances in research on these emergent pathogens. ..
  5. TOXOPLASMA ENCEPHALITIS IN AIDS: BRADYZOITE REGULATION
    Louis Weiss; Fiscal Year: 2009
    ....
  6. Maternal genitourinary infections and adverse perinatal outcomes
    Abdullah Hel Baqui; Fiscal Year: 2010
    ..infections between 12-16 weeks;those with abnormal vaginal flora (Nugent score >4) will be treated with oral clindamycin for 5 days, rescreened after 3 weeks, and those with persistent abnormal flora will be retreated with a second ..
  7. CONJUGAL TRANSFER OF BACTEROIDES ANTIBIOTIC RESISTANCES
    Abigail Salyers; Fiscal Year: 1999
    ..Resistance to two of the drugs of choice for treating Bacteroides infections, clindamycin and beta-lactam antibiotics has begun to appear and is beginning to complicate treatment of Bacteroides ..
  8. Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Trial
    Alan Thevenet N Tita; Fiscal Year: 2010
    ..prior to surgery;concurrently, both groups will also receive standard single-dose cefazolin prophylaxis (or clindamycin if allergic to cephalosporin)...
  9. Epidemic CA-MRSA: Molecular Epidemiology and Immunology
    ROBERT S contact DAUM; Fiscal Year: 2010
    We are proposing studies utilizing the patients enrolled in the DMID-funded "Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-..
  10. CONJUGAL TRANSFER OF BACTEROIDES ANTIBIOTIC RESISTANCES
    Abigail Salyers; Fiscal Year: 1993
    ..that codes for resistance to erythromycin (Emr) The same gene that codes for Emr also codes for resistance to clindamycin, one of the few antibiotics that is effective for treating Bacteroides infections...
  11. Oral Immunotherapy for C. difficile Disease via Bacteria
    Thomas Parks; Fiscal Year: 2005
    ..secreting scFv against toxins A and B will then be tested in a well-established animal model of CDAD, the clindamycin-treated hamster...
  12. Therapy and Prevention for Bacterial Vaginosis
    Jane Schwebke; Fiscal Year: 2006
    ..The current therapy for BV consists of seven days of oral or topical metronidazole or clindamycin. However, there is a growing concern that eradication of organisms from the lower genital tract may be ..
  13. Primaquine-binding proteins identified in Pneumocystis
    SHERRY QUEENER; Fiscal Year: 2006
    Primaquine, an 8-aminoquinoline, with clindamycin is the most effective clinical alternative to standard therapy for patients with pneumonia caused by Pneumocystis, but the mechanism of action of 8-aminoquinolines against the organism ..
  14. Tinidazole for the Treatment of Bacterial Vaginosis
    Jane Schwebke; Fiscal Year: 2007
    ..Current treatments for BV with metronidazole or clindamycin are suboptimal with cure rates at approximately 70% and high recurrence rates...
  15. TNF Mediated Immune Defense Against Listeria Infection
    Eric Pamer; Fiscal Year: 2007
    ....
  16. Catheter Dwell Time and Risk of Bloodstream Infections in Hospitalized Neonates
    Aaron M Milstone; Fiscal Year: 2010
    ..This project will help to develop evidence-based strategies to prevent bloodstream infections among vulnerable infants hospitalized in the neonatal intensive care unit. ..
  17. Infection, Inflammation and Preeclampsia
    Catherine Haggerty; Fiscal Year: 2009
    ..Finally, cytokine and CRP testing may prove to be effective tools for identifying women at risk for developing preeclampsia. ..
  18. Infection, Inflammation and Preeclampsia
    Catherine Haggerty; Fiscal Year: 2007
    ..Finally, cytokine and CRP testing may prove to be effective tools for identifying women at risk for developing preeclampsia. ..
  19. Microsporidiosis:A Therapeutic Target
    Louis Weiss; Fiscal Year: 2003
    ....
  20. Toxoplasma encephalitis in AIDS: Bradyzoite Regulation
    Louis Weiss; Fiscal Year: 2007
    ....
  21. NEW OPPORTUNISTIC INFECTIONS IN AIDS--MICROSPORIDIOSIS
    Louis Weiss; Fiscal Year: 2002
    ..It is anticipated that the results of these studies will further studies to identify drug targets for interfering with polar tube development and/or function in future studies. ..
  22. Three Periodontal Therapies in Current & Non-Smokers
    Anne Haffajee; Fiscal Year: 2007
    ..The proposed investigation should provide a model to examine methods that could be useful in treating compromised patients whether compromised by harmful habits such as smoking, systemic disease, or genetic background. ..
  23. Novel Bacterial Pathogens in Pelvic Inflammatory Disease
    Catherine L Haggerty; Fiscal Year: 2010
    ..Knowledge of the risk factors, clinical characteristics, treatment efficacy, and morbidity of L. sanguinegens/amnionii, A. vaginae, BVAB, and UU-2 PID will direct future clinical and public health recommendations. ..
  24. Regulation of Lipid Metabolism in Human Sebaceous Glands
    Diane Thiboutot; Fiscal Year: 2006
    ..Data generated from the proposed experiments will advance our understanding of the mechanisms regulating sebum production and can lead to identification of potential additional therapeutic target sites in the treatment of acne. ..
  25. Novel Bacterial Pathogens in Pelvic Inflammatory Disease
    Catherine Haggerty; Fiscal Year: 2009
    ..Knowledge of the risk factors, clinical characteristics, treatment efficacy, and morbidity of L. sanguinegens/amnionii, A. vaginae, BVAB, and UU-2 PID will direct future clinical and public health recommendations. ..
  26. Mycoplasma Genitalium and Pelvic Inflammatory Disease
    Catherine Haggerty; Fiscal Year: 2007
    ..Exploring the role of M. genitalium in PID is imperative to optimize diagnosis and treatment and prevent reproductive morbidity among women with nongonococcal/nonchlamydial PID. ..
  27. Regulation of human sebaceous glands by 13-cis retinoic acid
    Diane Thiboutot; Fiscal Year: 2007
    ..The findings of these studies not only have the potential to advance our understanding of retinoid action in acne, but can lead to advances in the understanding of these agents in cancer biology and in innate immunity as well. ..
  28. Mechanisms of Tandem Repeat Deletion in Group B Strep
    KAREN PUOPOLO; Fiscal Year: 2006
    ..The training goal of this project is to prepare the applicant for a career in bacterial genetic research by providing didactic education and the opportunity to develop laboratory expertise in this rapidly evolving field. ..
  29. Patient-Centered Informatics System to Enhance Health Care in Rural Communities
    Matthew Samore; Fiscal Year: 2007
    ..Our implementation of an education campaign within a rural public health framework will help extend the benefits to underserved populations and to guide nationwide dissemination efforts. ..
  30. Intermountain Center of Excellence for Infection Prevention Strategies
    Matthew Samore; Fiscal Year: 2007
    ..RESEARCH GRANT TABLE OF CONTENTS Page Numbers Face Page .................................................................................................................................................. 1 Description, ..
  31. Rural Trial of Clinic Order Entry with Decision Support
    Matthew Samore; Fiscal Year: 2006
    ..The cost impact of the intervention will be measured to allow a comprehensive assessment of the value of this HIT. ..